Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2004 2
2006 1
2007 1
2009 2
2010 5
2011 2
2012 7
2013 11
2014 11
2015 11
2016 6
2017 8
2018 10
2019 12
2020 6
2021 7
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30764769

101 results

Results by year

Filters applied: . Clear all
Page 1
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Stalenhoef JE, van Nieuwkoop C, Wilson DC, van der Starre WE, van der Reijden TJK, Delfos NM, Leyten EMS, Koster T, Ablij HC, van 't Wout JJW, van Dissel JT. Stalenhoef JE, et al. BMC Infect Dis. 2019 Feb 14;19(1):161. doi: 10.1186/s12879-019-3789-6. BMC Infect Dis. 2019. PMID: 30764769 Free PMC article. Clinical Trial.
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.
van der Starre WE, Zunder SM, Vollaard AM, van Nieuwkoop C, Stalenhoef JE, Delfos NM, Van't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT. van der Starre WE, et al. Clin Microbiol Infect. 2014 Oct;20(10):1048-54. doi: 10.1111/1469-0691.12645. Clin Microbiol Infect. 2014. PMID: 25039648 Free article.
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT. van Nieuwkoop C, et al. BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3. BMC Med. 2017. PMID: 28366170 Free PMC article. Clinical Trial.
Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J, Wilson DC, Clemente-Callejo C, Román F, Bardés-Robles I, Jiménez I, Orviz E, Dastis-Arias M, Espinosa B, Tornero-Romero F, Giol-Amich J, González V, Llopis-Roca F; INFURG-SEMES investigators. Gonzalez Del Castillo J, et al. Crit Care. 2019 Oct 29;23(1):335. doi: 10.1186/s13054-019-2613-4. Crit Care. 2019. PMID: 31665092 Free PMC article.
Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, Legramante J, Galante A, Salerno G, Cardelli P, Di Somma S. Travaglino F, et al. BMC Infect Dis. 2012 Aug 8;12:184. doi: 10.1186/1471-2334-12-184. BMC Infect Dis. 2012. PMID: 22874067 Free PMC article.
Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.
Drozdov D, Thomer A, Meili M, Schwarz S, Kouegbe RB, Regez K, Guglielmetti M, Schild U, Conca A, Schäfer P, Reutlinger B, Ottiger C, Buchkremer F, Litke A, Schuetz P, Huber A, Bürgi U, Fux CA, Bock A, Müller B, Albrich WC; Triple P study group. Drozdov D, et al. Trials. 2013 Mar 22;14:84. doi: 10.1186/1745-6215-14-84. Trials. 2013. PMID: 23522152 Free PMC article. Clinical Trial.
MR- proADM to detect specific types of organ failure in infection.
Andrés C, Andaluz-Ojeda D, Cicuendez R, Nogales L, Martín S, Martin-Fernandez M, Almansa R, Calvo D, Esteban-Velasco MC, Vaquero-Roncero LM, Ríos-Llorente A, Sanchez-Barrado E, Muñoz-Bellvís L, Aldecoa C, Bermejo-Martin JF. Andrés C, et al. Eur J Clin Invest. 2020 Jun;50(6):e13246. doi: 10.1111/eci.13246. Epub 2020 May 19. Eur J Clin Invest. 2020. PMID: 32307701
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.
Elke G, Bloos F, Wilson DC, Brunkhorst FM, Briegel J, Reinhart K, Loeffler M, Kluge S, Nierhaus A, Jaschinski U, Moerer O, Weyland A, Meybohm P; SepNet Critical Care Trials Group. Elke G, et al. Crit Care. 2018 Mar 21;22(1):79. doi: 10.1186/s13054-018-2001-5. Crit Care. 2018. PMID: 29562917 Free PMC article. Clinical Trial.
101 results